GTx Inc. (GTXI)

1.51 +0.03 (+2.027%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 1.48

Price Open 1.45

Volume: 733,183

Avg Volume: 1.28M

Market Cap: 36.32M

P/E Ratio -0.81

52 Wk Range 1.32-25.6



GTXI Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
12.61M
3.99M
0.72
31.62%

2018-09-28
12.61M
1.96M
0.92
15.58%

2018-09-14
12.61M
1.98M
8.66
15.74%

2018-08-31
12.61M
2M
12.57
15.87%




GTXI Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-10-22
Q3 2018
N/A
-0.30 (2)
-0.39
-0.09

2018-08-14
Q2 2018
N/A
-0.43 (2)
-0.43
0.00

2018-05-21
Q1 2018
N/A
-0.43 (2)
0.00
0.00

2018-05-15
Q1 2018
N/A
-0.43 (2)
-0.62
-0.19

News

GTx misses by $0.09 (2018-10-22 07:36 SeekingAlpha)

GTx (NASDAQ: GTXI ): Q3 GAAP EPS of -$0.39 misses by $0.09. More news on: GTx, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …

 

GTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update (2018-10-22 07:00 Business Wire)

GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter ended September 30, 2018, and provided a corporate update. During the quarter, we turned our focus to the ongoing selective androgen receptor degrader program and the potential of our novel selective …

 


Statistics

Shares Outstanding: 24.05M

Top 15 Institution Percent: 32.90

Price To Sales: N/A

Price To Book: 1.15

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -87.98

Return On Equity: -109.06

Profit Margin: N/A

Price History

Beta: 1.61

50-day Moving Avg: 5.54

200-day Moving Avg: 14.84

YTD Change: -86.87

5-day Change: 2.03

1-month Change: -19.68

3-month Change: -91.78

6-month Change: -91.81

1-year Change: -84.56

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: GTx Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.gtxinc.com

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.